SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-072922
Filing Date
2020-06-12
Accepted
2020-06-12 16:17:02
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2022479d1_3.html 3  
1 FORM 3 tm2022479d1_3.xml 3 2204
2 EXHIBIT 24 tm2022479d1_ex24.htm EX-24 7472
  Complete submission text file 0001104659-20-072922.txt   11302
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1517 CHAMPLAIN CREST WAY CARY NC 27513
Business Address 1517 CHAMPLAIN CREST WAY CARY NC 27513 781-308-0823
Syntone Ventures LLC (Reporting) CIK: 0001814394 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37759 | Film No.: 20960393